SGLT2i: beyond the glucose-lowering effect

Sodium/glucose cotransporter-2 inhibitors (SGLT2i) are a new type of glucose-lowering drug that can reduce blood glucose by inhibiting its reabsorption in proximal tubules and by promoting urinary glucose excretion. SGLT2i are widely used in the clinical treatment of type 2 diabetes mellitus (T2DM)....

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Lihua, Yuan, Cheng, Chen, Guopeng, Zhang, Changjiang, Wu, Xiaoyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320582/
https://www.ncbi.nlm.nih.gov/pubmed/32590982
http://dx.doi.org/10.1186/s12933-020-01071-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320582/
https://www.ncbi.nlm.nih.gov/pubmed/32590982
http://dx.doi.org/10.1186/s12933-020-01071-y

Ejemplares similares